Skip to main content

A study on autism done at IRB Barcelona in the running for the “Vanguardia de la Ciencia” Award

Institutional
30 Jan 19

Images

Participants

Contact

Image
Communication Officer
Tel.+34 93 40 37255

The research focuses on the CPEB4 protein, a key molecule in the development of this neurological disorder.

The award is a joint initiative of La Vanguardia and the Fundació Catalunya-La Pedrera.

For the fifth consecutive year, the Institute for Research in Biomedicine (IRB Barcelona) has been nominated for the “Vanguardia de la Ciencia” Award, thanks to research into autism, done in collaboration with the Centre for Molecular Biology "Severo Ochoa" (CBMSO), which belongs to the Spanish National Research Council (CSIC). The work in question established that the CPEB4 protein, which coordinates the expression of hundreds of genes necessary for neuronal activity, is altered in the brains of patients with this neurological disorder.

The scientists Raúl Méndez, head of the Translational Control of Cell Cycle and Differentiation laboratory at IRB Barcelona, and José J. Lucas, at CSIC, were addressing the influence of CPEB proteins in Huntington’s disease when they discovered that these proteins orchestrate the genome, which regulates the activity of thousands of genes.

CPEB proteins determine whether these genes are activated or silenced at the correct time during embryonic development. The scientists observed that in mouse models of Huntington’s disease, the alteration in CPEBs affected the genes associated with predisposition to autism.

Both researchers believe that a strategy to restore CPEB4 activity in the brains of those affected would improve the treatment of autism spectrum disorder.  This study is a clear example of the tight association between basic biomedicine research and our knowledge of diseases.

Published in the journal Nature, the study concludes that a defect in CPEB4 could be the link between environmental factors that alter brain development and the genes that determine susceptibility to autism.

9th “Vanguardia de la Ciencia” Award

The “Vanguardia de la Ciencia” Award, a joint initiative of the La Vanguardia newspaper and the Fundació Catalunya-La Pedrera, seeks to increase the visibility of scientists conducting frontier research and bring this research closer to society. Candidate selection has been based on two criteria, namely the excellence of the research and that this research has been headed by a Spanish institution.

Research in the fields of physics, chemistry and social science selected by an interdisciplinary scientific committee has also been nominated.

 

Vote for our research until February 28, here:

https://www.lavanguardia.com/ciencia/20190125/461059281/vanguardia-ciencia-origen-autismo.html

 

 

About IRB Barcelona

Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 27 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).